Blood-pressure reduction with LCZ696
- PMID: 20236699
- DOI: 10.1016/S0140-6736(10)60363-7
Blood-pressure reduction with LCZ696
Comment on
-
Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study.Lancet. 2010 Apr 10;375(9722):1255-66. doi: 10.1016/S0140-6736(09)61966-8. Epub 2010 Mar 16. Lancet. 2010. PMID: 20236700 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical